Fibroblast Growth Factor Type 2 (FGF2) Administration Attenuated the Clinical Manifestations of Preeclampsia in a Murine Model Induced by L-NAME

por Martinez-Fierro, Margarita L, Hernadez-Delgadillo, Gloria Patricia, Flores-Mendoza, Jose Feliciano, Alvarez-Zuñiga, Claudia Daniela, Diaz-Lozano, Martha Lizeth, Delgado-Enciso, Ivan, Romero-Diaz, Viktor Javier, Lopez-Saucedo, Adrian, Rodriguez-Sanchez, Iram Pablo, Marino-Martinez, Ivan Alberto, Garza-Veloz, Idalia
Publicado 2021